Bioprocess Validation Market to hit USD 1.03 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank of Canada from $369.00 to $481.00. They now have an "outperform" rating on the stock.
Microbiome Diagnostics Market Revenue Projections to 2034 by Product, Technology, Sample, Application, End-user, and by Region [Yahoo! Finance]
Bio-Rad (BIO) Down 5.5% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts, Strategies, Trends, Forecasts with Executive Guides [Yahoo! Finance]